Sheridan Capital Partners Announces Formation of Ascend Plastic Surgery Partners
Gracie Gottlieb | 27 October, 2023
Sheridan Capital Partners, a Chicago-based healthcare private equity firm, has exciting news to share. They have announced the formation of Ascend Plastic Surgery Partners, a plastic surgery physician practice management company. Ascend is a result of the combination of five plastic surgery practices and two standalone MedSpas.
Headquartered in Atlanta, Georgia, Ascend currently offers its services in Alabama, New Mexico, South Carolina, and Utah. The company provides a comprehensive range of plastic surgery and med spa services to its patients. Dr. William Hedden, a board-certified and experienced surgeon, will be assuming the role of Chief Medical Officer in the newly formed entity.
Sheridan Capital Partners partnered with Dr. Hedden and a team of accomplished physicians to establish Ascend Plastic Surgery Partners. Through this partnership, Ascend aims to redefine excellence in plastic surgery and deliver unparalleled patient experiences and outcomes. Sheridan's extensive experience in building physician-centric practice management businesses, their dedication to a plastic surgery-focused platform, and their alignment with Ascend's clinical goals made them the ideal partner for this venture.
Nicholas Rowland, a Partner at Sheridan Capital Partners, comments on Ascend's position in the market, stating that it is an early mover in the highly fragmented cosmetic plastic surgery sector and one of the few platforms of scale dedicated to the specialty. The partnership between Ascend and Sheridan Capital Partners aims to build a differentiated, high-growth platform that attracts talented plastic surgeons and provides an elevated patient experience.
Chris McCrory, a Principal at Sheridan, adds that Ascend has the potential to advance the industry standard through its commitment to innovation, patient care, and clinical excellence.
The transaction was led by Jonathan Lewis, Nicholas Rowland, Christopher McCrory, Stephen Lestyan, and Munib Ansari at Sheridan Capital Partners. Legal counsel was provided by McDermott Will & Emery LLP. The financial terms of the transaction have not been disclosed.
About Ascend Plastic Surgery Partners:
Ascend Plastic Surgery Partners is a Management Services Organization (MSO) specializing in Plastic Surgery and Aesthetics. The company is dedicated to excellence, innovation, and patient care. Ascend brings together a network of highly accomplished plastic surgeons and their practices to advance the art and science of aesthetic medicine.
About Sheridan Capital Partners:
Sheridan Capital Partners is a healthcare private equity firm based in Chicago. They focus on lower middle market buyouts and growth equity in the U.S. and Canada. Sheridan partners with companies in the areas of providers and provider services, healthcare IT and outsourced services, and medical products. Their goal is to bring strategic resources to accelerate growth, build enduring value, and achieve strong results.
To learn more about Sheridan Capital Partners, please visit www.sheridancp.com.
Other Posts
- Analyzing Rice Partnership, LLC's Q4 2022 vs. Q1 2023 13F Holdings: Changes, Trends, and Insights
- Ccm Investment Advisers LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Broadleaf Partners, LLC Q3 2022 vs. Q4 2022: Analyzing 13F Holdings Changes
- Navigating the Seas of Investment: Towerpoint Wealth's Strategic Shifts from Q4 2023 to Q1 2024
- Investing in Q4 2022? Analyzing Cahaba Wealth Management, Inc.'s Q3 2022 and Q4 2022 13F Holdings.
- Investment Fund Update: Calton & Associates, Inc. Q4 2022 vs. Q1 2023
- Analyzing Raging Capital Management's Q2 2021 vs. Q3 2021 13F Holdings
- Selective Wealth Management, Inc. Q4 2022 vs. Q2 2023 13F Holdings Comparison
- Investing in the Top Companies: Williams Jones & Associates LLC Q1 2019 vs. Q2 2019 Holdings Comparison
- Edmonds Duncan Registered Investment Advisors, LLC Q2 2023 vs. Q3 2023: Analyzing Fund Holdings